The extent of late gadolinium enhancement can be assessed fast and reproducible using semi-quantitative method in patients with hypertrophic cardiomyopathy

The extent of late gadolinium enhancement can be assessed fast and reproducible using semi-quantitative method in patients with hypertrophic cardiomyopathy

Bibliographic Details
Main Authors:	Gommans Frank, Bakker Jeannette, Cramer Etienne, Kurvers Maurice J, Verheugt Freek W, Brouwer Marc A, Kofflard Marcel
Format:	Article
Language:	English
Published:	Elsevier 2013-01-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
by: Gommans Frank, et al.
Published: (2013-01-01)

Assessment of prognostic LV parameters with CMR in hypertrophic cardiomyopathy: impact of the papillary muscles
by: Gommans Frank, et al.
Published: (2012-02-01)

The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy
by: Deniz Alis, et al.
Published: (2021-04-01)

Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy
by: Gaston A. Rodriguez-Granillo, et al.
Published: (2016-01-01)

Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy
by: Germans Tjeerd, et al.
Published: (2010-05-01)

Further refining risk in hypertrophic cardiomyopathy with late gadolinium enhancement by CMR
by: Kramer, C, et al.
Published: (2018)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
by: Smith Brandon M, et al.
Published: (2013-01-01)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
by: Jassal Davinder S, et al.
Published: (2008-12-01)

Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy
by: Ana Raquel Barbosa, et al.
Published: (2020-11-01)

Utility of late gadolinium enhancement on magnetic resonance imaging in hypertrophic cardiomyopathy patients in an Indian cohort
by: Harikrishnan Gangadharakaimal, et al.
Published: (2023-09-01)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
by: Ismail Tevfik F, et al.
Published: (2013-01-01)

The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease
by: Shengliang Liu, et al.
Published: (2022-05-01)

High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy.
by: Tetsuo Konno, et al.
Published: (2014-01-01)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
by: Christina Doesch, et al.
Published: (2017-07-01)

Cardiac aldosterone in subjects with hypertrophic cardiomyopathy
by: Wenxia Chai, et al.
Published: (2006-12-01)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
by: Kyoung-Min Park, et al.
Published: (2016-01-01)

Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy
by: Zhang, Q, et al.
Published: (2021)

Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
by: Yang Zhi, et al.
Published: (2024-04-01)

Patterns of Left Ventricular Hypertrophy and Late Gadolinium Enhancement onCardiac Magnetic Resonanace in Patients with Hypertrophic Cardiomyopathy
by: Sobia Mehreen, et al.
Published: (2022-11-01)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy.
by: Dass, S, et al.
Published: (2012)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
by: Dass, S, et al.
Published: (2012)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
by: Dass Sairia, et al.
Published: (2012-02-01)

Global circumferential left ventricular strain impairment in hypertrophic cardiomyopathy: comparison to left ventricular hypertrophy and late gadolinium enhancement
by: Macron Laurent, et al.
Published: (2013-01-01)

Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population
by: Bradley S. Lander, et al.
Published: (2022-06-01)

Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy
by: Yang Ye, et al.
Published: (2021-11-01)

Relationship Between Obstructive Sleep Apnea and Late Gadolinium Enhancement and Their Effect on Cardiac Arrhythmias in Patients with Hypertrophic Obstructive Cardiomyopathy
by: Wang S, et al.
Published: (2021-03-01)

Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
by: Kate E. Bailey, et al.
Published: (2020-12-01)

Differential Expression of microRNAs in Hypertrophied Myocardium and Their Relationship to Late Gadolinium Enhancement, Left Ventricular Hypertrophy and Remodeling in Hypertrophic Cardiomyopathy
by: Chen Zhang, et al.
Published: (2022-08-01)

In Both Hypertrophic And Dilated Cardiomyopathy, Non-contrast T1 Mapping Provides Myocardial Tissue Characterization Beyond That Achieved By Late Gadolinium Enhancement.
by: Dass, S, et al.
Published: (2011)

The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death
by: Pedro Freitas, et al.
Published: (2019-08-01)

Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy
by: Zi-Yi Gu, et al.
Published: (2023-08-01)

PHENOTYPE OF THE ACTC E99K TRANSGENIC MOUSE REPRODUCES HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS
by: Song, W, et al.
Published: (2010)

Hypertrophic Cardiomyopathy
by: Asra K. Butt, et al.
Published: (2023-03-01)

Hypertrophic cardiomyopathy
by: Sarita Gore, et al.
Published: (2022-01-01)

Hypertrophic Cardiomyopathy
by: Polakit Teekakirikul, MD, et al.
Published: (2021-09-01)

Hypertrophic cardiomyopathy
by: Murillo de Oliveira Antunes, et al.
Published: (2020-04-01)

The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies
by: Karamitsos, T, et al.
Published: (2013)

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.
by: Karamitsos, T, et al.
Published: (2013)

Impact of late gadolinium enhancement extent, location, and pattern on ventricular tachycardia and major adverse cardiac events in patients with ischemic vs. non-ischemic cardiomyopathy
by: Emily Tat, et al.
Published: (2022-10-01)